Table 1 Correlation between LncRNA FTX expression and clinicopathological parameters in oral squamous cell carcinomas.
Features | Number | LncRNA FTX expression level | P | |
|---|---|---|---|---|
Low | High | |||
Age (years) | ||||
≤60 | 13 | 5 | 8 | 0.720 |
>60 | 27 | 12 | 15 | |
Gender | ||||
Male | 22 | 10 | 12 | 0.949 |
Female | 18 | 8 | 10 | |
Location | ||||
Tongue | 12 | 5 | 7 | 0.641 |
Gingival | 6 | 3 | 3 | |
Buccal | 10 | 6 | 4 | |
Others | 12 | 4 | 8 | |
Differentiation | ||||
Well | 10 | 7 | 3 | 0.048* |
Moderate | 20 | 5 | 15 | |
Poor | 10 | 3 | 7 | |
Tumor size | ||||
T1–T2 | 30 | 17 | 13 | 0.144 |
T3–T4 | 10 | 3 | 7 | |
Lymph node | ||||
pN− | 33 | 23 | 10 | 0.041* |
pN+ | 7 | 2 | 5 | |
Clinical stage | ||||
I–II | 34 | 26 | 8 | 0.034* |
III–IV | 6 | 2 | 4 | |
